A Phase 2 Study of PRX-03140 as Monotherapy in Alzheimer's Disease.

• Research type

  Research Study

• Full title

  A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PRX-03140 AS MONOTHERAPY IN SUBJECTS WITH ALZHEIMER’S DISEASE

• Contact name

  Craig W Ritchie

• Contact email

  c.ritchie@imperial.ac.uk

• Sponsor organisation

  EPIX Pharmaceuticals Inc.

• Eudract number

  2008-006337-27

• Clinicaltrials.gov Identifier

  NCT00693004

• Research summary

  Research Summary not published at request of researcher

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  09/H0502/7

• Date of REC Opinion

  24 Mar 2009

• REC opinion

  Further Information Favourable Opinion